• Demographic data | |
• Baseline data | |
• PRISM III score | |
• PELOD-2 score | |
• Clinical data for organ dysfunctions | |
• Red blood cell transfusion information | |
• Mechanical ventilation | |
• Evidence of infection | |
◦ nosocomial pneumonia | |
◦ blood stream infection | |
◦ sepsis | |
◦ severe sepsis | |
◦ septic shock | |
• Acute respiratory distress syndrome | |
• Deep venous thrombosis | |
• Any transfusion reaction | |
• Critical care interventions | |
◦ length of mechanical ventilation | |
◦ hemodynamic support | |
◦ renal replacement therapy | |
◦ fluid balance per day | |
◦ proportion of patients receiving erythropoietin | |
◦ vasoactive drugs | |
◦ mild to moderate hypothermia treatment | |
◦ systemic corticosteroids | |
◦ insulin administration | |
◦ starch colloids and/or gelatins | |
◦ plasmapheresis | |
◦ Molecular Adsorbent Re-Circulating System (MARS) | |
• Tranfusion interventions other than RBC administration (use and volume per kg) | |
◦ frozen plasma | |
◦ platelets | |
◦ cryoprecipitate | |
• Discharge status | |
• Mortality status | |
• Readmission information |